Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Impedimed Limited ( (AU:IPD) ).
ImpediMed Limited has announced that its 2025 Annual General Meeting will be held on November 18, 2025. The company is also accepting nominations for director positions, with a deadline for submissions set for September 26, 2025. This announcement is significant for stakeholders as it outlines key governance activities and timelines, potentially impacting the company’s strategic direction and leadership.
The most recent analyst rating on (AU:IPD) stock is a Buy with a A$0.14 price target. To see the full list of analyst forecasts on Impedimed Limited stock, see the AU:IPD Stock Forecast page.
More about Impedimed Limited
ImpediMed Limited operates in the medical technology industry, specializing in non-invasive medical devices that measure, monitor, and manage fluid status and tissue composition. The company focuses on providing solutions for healthcare providers to improve patient outcomes, particularly in the areas of lymphedema and heart failure.
Average Trading Volume: 2,109,362
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$71.27M
Find detailed analytics on IPD stock on TipRanks’ Stock Analysis page.